# Sooil Development Co., Ltd.

- Location (FDA's records): North Attleboro, MA
- FDA decisions: 4 (2000–2007): 4 510(k) clearances
- Product codes: LZG (3), MRZ (1)
- Predicates its devices cite: 7 (3 its own); citations of its devices by later devices: 4 (3 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Spectrx, Inc.: 1 (https://510kreport.com/company/spectrx)
- Applied Diabetes Research, Incorporated: 1 (https://510kreport.com/company/applied-diabetes-research)
- Sterling Medivations, Inc.: 1 (https://510kreport.com/company/sterling-medivations)
- Medtronic Minimed: 1 (https://510kreport.com/company/medtronic-minimed)

## Firms that cite its devices most
- Cane S.R.L.: 1 (https://510kreport.com/company/cane)

## Its most-cited devices
- K001604: Dana Diabecare (2000), cited by 3
- K022317: Dana Diabecare II Insulin Pump & Superline-Easyrelease, Soft-Release-ST, & Soft-Release-R Infusion Sets (2002), cited by 1

## Recent decisions
- K071418: Dana 3CC Syringe Insulin Reservoir (Sep 4, 2007)
- K063126: Dana Diabecare Iis (Feb 2, 2007)
- K022317: Dana Diabecare II Insulin Pump & Superline-Easyrelease, Soft-Release-ST, & Soft-Release-R Infusion Sets (Aug 2, 2002)
- K001604: Dana Diabecare (Aug 14, 2000)

Source page: https://510kreport.com/company/sooil-development